Post-approval studies (Phase 4)Study completedNCT03142321
What this trial is testing
Defining Predictors of RT Response to Vedolizumab in IBD
Who this might be right for
Crohn Disease of Small Intestine
Washington University School of Medicine 48
Showing 20 of 0 results